American International Group, Inc. Fulgent Genetics, Inc. Transaction History

American International Group, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$21.55 - $29.29 $2,090 - $2,841	-97 Reduced 0.87%	11,026 $239,000
Q4 2023 Feb 13, 2024	SELL	$23.64 - $30.27 $2,411 - $3,087	-102 Reduced 0.91%	11,123 $321,000
Q3 2023 Nov 13, 2023	BUY	$26.74 - $40.81 $7,059 - $10,773	264 Added 2.41%	11,225 $300,000
Q2 2023 Aug 04, 2023	SELL	$28.52 - $40.7 $11,037 - $15,750	-387 Reduced 3.41%	10,961 $405,000
Q1 2023 May 12, 2023	BUY	$29.39 - $36.27 $1,763 - $2,176	60 Added 0.53%	11,348 $354,000
Q4 2022 Feb 10, 2023	SELL	$29.23 - $40.28 $12,451 - $17,159	-426 Reduced 3.64%	11,288 $336,000
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $6,484 - $10,899	171 Added 1.48%	11,714 $447,000
Q2 2022 Aug 12, 2022	SELL	$47.98 - $62.75 $14,441 - $18,887	-301 Reduced 2.54%	11,543 $629,000
Q1 2022 May 13, 2022	SELL	$49.85 - $96.11 $36,490 - $70,352	-732 Reduced 5.82%	11,844 $739,000
Q4 2021 Feb 11, 2022	SELL	$77.3 - $105.0 $20,793 - $28,245	-269 Reduced 2.09%	12,576 $1.27 Million
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $7,487 - $11,087	-100 Reduced 0.77%	12,845 $1.16 Million
Q2 2021 Aug 13, 2021	BUY	$66.8 - $100.45 $239,277 - $359,811	3,582 Added 38.26%	12,945 $1.19 Million
Q1 2021 May 07, 2021	BUY	$59.3 - $183.85 $16,366 - $50,742	276 Added 3.04%	9,363 $905,000
Q4 2020 Feb 12, 2021	BUY	$31.01 - $52.1 $68,780 - $115,557	2,218 Added 32.29%	9,087 $473,000
Q3 2020 Nov 04, 2020	BUY	$15.89 - $50.51 $15,206 - $48,338	957 Added 16.19%	6,869 $275,000
Q2 2020 Aug 12, 2020	BUY	$8.89 - $18.28 $52,557 - $108,071	5,912 New	5,912 $95,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.